These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16714924)

  • 21. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations.
    Kraft SP; Lang AE
    Can J Neurol Sci; 1988 Aug; 15(3):276-80. PubMed ID: 3208210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion.
    Carruthers J; Stubbs HA
    Can J Neurol Sci; 1987 Feb; 14(1):42-5. PubMed ID: 3815164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study.
    Taylor JD; Kraft SP; Kazdan MS; Flanders M; Cadera W; Orton RB
    Can J Ophthalmol; 1991 Apr; 26(3):133-8. PubMed ID: 2054723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
    Arthurs B; Flanders M; Codère F; Gauthier S; Dresner S; Stone L
    Can J Ophthalmol; 1987 Feb; 22(1):24-8. PubMed ID: 3815152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.
    Dutton JJ; Buckley EG
    Ophthalmology; 1988 Nov; 95(11):1529-34. PubMed ID: 3211461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of botulinum toxin type A for the treatment of facial spasm.
    Serrano LA
    Bol Asoc Med P R; 1993; 85(1-3):7-11. PubMed ID: 8060446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.
    Snir M; Weinberger D; Bourla D; Kristal-Shalit O; Dotan G; Axer-Siegel R
    Am J Ophthalmol; 2003 Jul; 136(1):99-105. PubMed ID: 12834676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias.
    Vissenberg I; Dieleman-Smet H; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1993; 248():77-82. PubMed ID: 8044337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
    Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
    Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of botulinum toxin in the medical management of benign essential blepharospasm.
    Perman KI; Baylis HI; Rosenbaum AL; Kirschen DG
    Ophthalmology; 1986 Jan; 93(1):1-3. PubMed ID: 3951806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?
    Pang AL; O'Day J
    Clin Exp Ophthalmol; 2006 Jul; 34(5):441-4. PubMed ID: 16872340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain relief in patients receiving periocular botulinum toxin A.
    Harrison AR; Erickson JP; Anderson JS; Lee MS
    Ophthalmic Plast Reconstr Surg; 2008; 24(2):113-6. PubMed ID: 18356715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of blepharospasm with high dose brow injection of botulinum toxin.
    Kristan RW; Stasior OG
    Ophthalmic Plast Reconstr Surg; 1987; 3(1):25-7. PubMed ID: 3154571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin in the treatment of facial dyskinesias.
    Chong PN; Ong B; Chan R
    Ann Acad Med Singap; 1991 Mar; 20(2):223-7. PubMed ID: 1883180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
    Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
    J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?
    Boyle MH; McGwin G; Flanagan CE; Vicinanzo MG; Long JA
    Ophthalmic Plast Reconstr Surg; 2009; 25(2):81-4. PubMed ID: 19300145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin for the treatment of essential blepharospasm.
    Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC
    Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.